HR 4837 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To direct the Secretary of Veterans Affairs to expand a directive of the Veterans Health Administration regarding informed consent to apply to certain types of medications.
Summary
- Directs the Secretary of Veterans Affairs to update VHA Directive 1005 (regarding informed consent for long-term opioid therapy) to apply to antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
25 cosponsors
- Del. King-Hinds, Kimberlyn [R-MP-At Large] (R-MP)
- Del. Radewagen, Aumua Amata Coleman [R-AS-At Large] (R-AS)
- Rep. Barr, Andy [R-KY-6] (R-KY)
- Rep. Barrett, Tom [R-MI-7] (R-MI)
- Rep. Bergman, Jack [R-MI-1] (R-MI)
- Rep. Ciscomani, Juan [R-AZ-6] (R-AZ)
- Rep. Davis, Donald G. [D-NC-1] (D-NC)
- Rep. Edwards, Chuck [R-NC-11] (R-NC)
- Rep. Fields, Cleo [D-LA-6] (D-LA)
- Rep. Fitzgerald, Scott [R-WI-5] (R-WI)
- Rep. Grothman, Glenn [R-WI-6] (R-WI)
- Rep. Guest, Michael [R-MS-3] (R-MS)
- Rep. Hamadeh, Abraham J. [R-AZ-8] (R-AZ)
- Rep. Harrigan, Pat [R-NC-10] (R-NC)
- Rep. Hill, J. French [R-AR-2] (R-AR)
- Rep. Kean, Thomas H. [R-NJ-7] (R-NJ)
- Rep. Kennedy, Mike [R-UT-3] (R-UT)
- Rep. Lawler, Michael [R-NY-17] (R-NY)
- Rep. Massie, Thomas [R-KY-4] (R-KY)
- Rep. Miller, Max L. [R-OH-7] (R-OH)
- Rep. Owens, Burgess [R-UT-4] (R-UT)
- Rep. Self, Keith [R-TX-3] (R-TX)
- Rep. Stauber, Pete [R-MN-8] (R-MN)
- Rep. Van Drew, Jefferson [R-NJ-2] (R-NJ)
- Rep. Van Orden, Derrick [R-WI-3] (R-WI)
Money behind the sponsor
Top reported contributors to Gus M. Bilirakis’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Gus M. Bilirakis → · Outside spending →
Actions (3)
- Dec 19, 2025 Referred to the Subcommittee on Health. · house
- Aug 1, 2025 Referred to the House Committee on Veterans' Affairs. · house
- Aug 1, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
August 1, 2025
Mr. Bilirakis (for himself, Mr. Bergman, and Mr. Self) introduced the following bill; which was referred to the Committee on Veterans’ Affairs
A BILL
To direct the Secretary of Veterans Affairs to expand a directive of the Veterans Health Administration regarding informed consent to apply to certain types of medications.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Written Informed Consent Act”.
SEC. 2. EXPANSION OF CERTAIN DIRECTIVE OF THE VETERANS HEALTH ADMINISTRATION REGARDING INFORMED CONSENT TO APPLY TO CERTAIN TYPES OF MEDICATIONS.
The Secretary of Veterans Affairs shall update VHA Directive 1005 (dated May 13, 2020, and titled “Informed Consent For Long-term Opioid Therapy For Pain”) to apply to the following types of medications:
(1) Antipsychotics.
(2) Stimulants.
(3) Antidepressants.
(4) Anxiolytics.
(5) Narcotics. <all>
Comments